|
EFTUD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14219999997256E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.355560E-04 |
| Normal-vs-Stage2 |
1.723970E-01 |
| Normal-vs-Stage3 |
7.252100E-02 |
| Normal-vs-Stage4 |
9.783400E-01 |
| Stage1-vs-Stage2 |
6.523200E-01 |
| Stage1-vs-Stage3 |
6.768000E-01 |
| Stage1-vs-Stage4 |
1.465810E-01 |
| Stage2-vs-Stage3 |
9.421800E-01 |
| Stage2-vs-Stage4 |
3.571400E-01 |
| Stage3-vs-Stage4 |
2.799200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.27280000000474E-05 |
| Normal-vs-AfricanAmerican |
1.999390E-04 |
| Normal-vs-Asian |
5.203600E-01 |
| Caucasian-vs-AfricanAmerican |
3.807000E-01 |
| Caucasian-vs-Asian |
7.291000E-01 |
| AfricanAmerican-vs-Asian |
5.260000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.822600E-04 |
| Normal-vs-Female |
2.04570000050808E-07 |
| Male-vs-Female |
4.922600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.408260E-02 |
| Normal-vs-Extreme_Weight |
4.698600E-03 |
| Normal-vs-Obese |
1.638280E-04 |
| Normal-vs-Extreme_Obese |
3.587600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.182400E-01 |
| Normal_Weight-vs-Obese |
4.376200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.928600E-01 |
| Extreme_Weight-vs-Obese |
1.205360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.528600E-01 |
| Obese-vs-Extreme_Obese |
6.744600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.417800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.845070E-04 |
| Normal-vs-Age(61-80Yrs) |
3.50540000000343E-05 |
| Normal-vs-Age(81-100Yrs) |
3.722400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.624600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.615000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.427000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.941200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.132600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.417000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.20569999997977E-06 |
| Normal-VS-Type2 PRCC |
9.196700E-03 |
| Normal-VS-KIRP CIMP |
5.277800E-02 |
| Normal-VS-Unclassified PRCC |
1.105820E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.318200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.912000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.919560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.893400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.881800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.277600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.364400E-01 |
| Normal-vs-N1 |
4.267700E-02 |
| Normal-vs-N2 |
8.595700E-02 |
| N0-vs-N1 |
2.268200E-01 |
| N0-vs-N2 |
2.015400E-01 |
| N1-vs-N2 |
9.818000E-02 |
|
|
